Coherus Oncology, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 12.3M | 12.7M | 11.6M | 10.3M | 7.6M | 54.1M | 70.8M | 65.0M |
| Cost of Goods Sold | 4.7M | 4.9M | 4.7M | 4.4M | 3.7M | 33.9M | 20.7M | 29.6M |
| Gross Profit | 7.6M | 7.8M | 6.9M | 5.8M | 3.9M | 20.3M | 50.0M | 35.4M |
| R&D Expenses | 20.7M | 30.1M | 26.3M | 25.3M | 23.3M | 21.2M | 21.7M | 20.8M |
| Operating Expenses | 43.8M | 53.7M | 49.1M | 51.3M | 49.3M | 62.5M | 56.4M | 55.9M |
| Operating Income | -36.2M | -45.9M | -42.2M | -45.5M | -45.4M | -42.2M | -6.4M | -20.5M |
| Other Income / Gains | -784K | -467K | -2.3M | 624K | -2.0M | -8.4M | -4.4M | 7.6M |
| Net Income | -37.9M | -37.3M | -35.1M | -41.3M | -56.6M | -50.7M | -10.8M | -12.9M |
| EPS (Diluted) | -0.28 | -0.31 | -0.30 | -0.39 | -0.49 | -0.44 | -0.093 | -0.11 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.619 | 0.612 | 0.595 | 0.57 | 0.513 | 0.375 | 0.707 | 0.545 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 23.1M | 23.6M | 22.8M | 26.0M | 26.0M | 41.3M | 34.7M | 35.2M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 48.5M | 58.6M | 53.8M | 55.7M | 53.0M | 96.4M | 77.2M | 85.5M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 2.2M | 2.2M | 2.3M | 2.3M | 2.1M | 5.3M | 5.4M | 5.3M |
| Depreciation And Amortization | 881K | 896K | 966K | 1.0M | 1.0M | 1.0M | 1.5M | 1.2M |
| Ebitda | -33.9M | -43.2M | -41.2M | -41.6M | -44.2M | -44.3M | -3.8M | -6.4M |
| Ebitdaratio | -2.751 | -3.389 | -3.563 | -4.054 | -5.817 | -0.819 | -0.054 | -0.098 |
| Operating Income Ratio | -2.937 | -3.599 | -3.65 | -4.436 | -5.979 | -0.78 | -0.09 | -0.316 |
| Income Before Tax | -36.9M | -46.3M | -44.5M | -44.9M | -47.4M | -50.7M | -10.8M | -12.9M |
| Income Before Tax Ratio | -3.00 | -3.636 | -3.847 | -4.375 | -6.237 | -0.936 | -0.152 | -0.199 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -3.082 | -2.924 | -3.034 | -4.031 | -7.444 | -0.936 | -0.152 | -0.199 |
| Epsdiluted | -0.28 | -0.31 | -0.30 | -0.39 | -0.49 | -0.44 | -0.093 | -0.11 |
| Weighted Average Shs Out | 136.4M | 120.4M | 116.2M | 116.1M | 115.9M | 115.4M | 115.2M | 114.8M |
| Weighted Average Shs Out Dil | 136.4M | 120.4M | 116.2M | 116.1M | 115.9M | 115.4M | 115.2M | 114.8M |